+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mumps Virus Vaccine Live Market - Global Forecast 2025-2030- Product Image
Mumps Virus Vaccine Live Market - Global Forecast 2025-2030- Product Image
Sale

Mumps Virus Vaccine Live Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6126890
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mumps virus vaccine market is navigating a period of transformation as renewed public health attention, regulatory shifts, and technological advancements converge to redefine product development and deployment strategies. Senior decision-makers are seeking actionable intelligence to address emerging industry challenges and seize growth opportunities in this dynamic landscape.

Market Snapshot: Mumps Virus Vaccine Market Overview

Driven by recent mumps outbreaks and ongoing immunization challenges, this market demonstrates resilient growth potential. Key drivers include evolving immunization schedules, heightened regulatory oversight, and the integration of digital health tools to enhance vaccine tracking and reporting. The North American and Asia-Pacific regions exhibit particularly robust participation, underpinned by policy support and expanding manufacturing hubs. Adoption of combination and monovalent mumps vaccines remains strong across strategic target cohorts, supporting sustainable volume pipelines and supporting public health mandates.

Scope & Segmentation

This analysis delivers comprehensive segmentation and regional insights crucial for informed planning and strategy:

  • Vaccine Types: Combination vaccines (MMR, MMRV) and monovalent single-pathogen options address both broad prevention and focused outbreak response.
  • Distribution Channels: Market access extends through clinics, hospital pharmacies (public and private), online pharmacies (direct-to-consumer, third-party), and retail pharmacies (chain, independent).
  • Age Groups: Segments include pediatric, adolescent, and adult populations, driving formulation nuances and dosing strategies.
  • Technologies: Key platforms feature DNA, live attenuated, and recombinant mumps vaccines, each influencing storage requirements and immunogenic profiles.
  • Administration Routes: Intramuscular and subcutaneous delivery optimize patient adherence and operational flexibility.
  • Dose Types: Multi-dose and single-dose formats are available, impacting inventory management and waste reduction efforts.
  • Formulations: Liquid solution and lyophilized powder support a range of logistical preferences and geographic deployment needs.
  • Primary Regions: Americas (United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, among others); Asia-Pacific (China, India, Japan, Australia, South Korea, and several Southeast Asian markets).
  • Key Companies: Merck & Co., GlaxoSmithKline, Serum Institute of India, China National Biotec Group, Walvax Biotechnology, Chengdu Institute of Biological Products, Beijing Institute of Biological Products, Shanghai Institute of Biological Products, PT Bio Farma, Instituto Butantan.

Key Takeaways for Senior Decision-Makers

  • Innovations in vaccine platforms, such as DNA-based and recombinant technologies, are shaping both immunogenic performance and manufacturing adaptability.
  • Stakeholder collaboration is expanding, with biotechnology and pharmaceutical firms forming partnerships to accelerate clinical research and streamline regulatory submissions across multiple markets.
  • Data-driven immunization tracking tools and digital outreach strategies are transitioning vaccine deployment from mass campaigns to precise, cohort-focused initiatives.
  • Market access strategies increasingly rely on diversified distribution, with online and retail pharmacy channels extending reach beyond traditional clinical settings.
  • Supply chain innovation, including single-use bioreactors and alternative sourcing models, is reducing lead times and risk while supporting sustainability goals.
  • Regional differences in procurement models and public-private partnership frameworks make locally tailored strategies essential for market entry and expansion.

Tariff Impact: United States 2025 Tariffs

In 2025, new United States tariffs on imported biopharmaceutical equipment and vaccine components triggered higher input costs for manufacturers. To address this, leading firms increased domestic manufacturing and restructured procurement, with some extending validation and launch timelines for new formulations. These measures have fueled renegotiations of government contracts and creation of collaborative cost-sharing models, supporting both immunization targets and industry resilience.

Methodology & Data Sources

This research integrates qualitative interviews with regulatory and public health experts and industry stakeholders, supplemented by quantitative insights pulled from proprietary databases and peer-reviewed sources. Data triangulation and scenario analysis reinforce accuracy, while expert validation guides market forecasting and segmentation assessments.

Mumps Virus Vaccine Market: Why This Report Matters

  • Delivers granular segmentation and regional breakdowns, supporting market entry, channel optimization, and resource prioritization decisions.
  • Equips executive teams to respond effectively to regulatory, technological, and supply chain disruptions in real time.
  • Provides actionable recommendations for integrating digital health tools, accelerating R&D, and building resilient manufacturing operations under shifting trade dynamics.

Conclusion

The mumps virus vaccine market is evolving amid shifting epidemiological, regulatory, and technological priorities. Strategic clarity and proactive engagement are essential for sustainable growth and effective public health outcomes.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of next-generation live attenuated mumps vaccines leveraging reverse genetics for enhanced immunogenicity and safety profiles
5.2. Increasing investment in combination measles-mumps-rubella-varicella (MMRV) vaccine formulations to improve immunization compliance and coverage rates
5.3. Adoption of thermostable live mumps vaccines in low-resource settings to reduce cold chain dependency and wastage
5.4. Advancements in genomic surveillance of mumps virus strains to inform live vaccine strain selection and strengthen outbreak prevention strategies
5.5. Rise of personalized vaccine schedules integrating live attenuated mumps vaccination protocols for immunocompromised and high-risk populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Mumps Virus Vaccine Live Market, by Vaccine Type
8.1. Introduction
8.2. Combination Vaccine
8.2.1. Mmr Vaccine
8.2.2. MmrV Vaccine
8.3. Monovalent Vaccine
8.3.1. Single Pathogen Vaccine
9. Mumps Virus Vaccine Live Market, by Distribution Channel
9.1. Introduction
9.2. Clinic
9.2.1. Community Clinic
9.2.2. Specialty Clinic
9.3. Hospital Pharmacy
9.3.1. Private Hospital
9.3.2. Public Hospital
9.4. Online Pharmacy
9.4.1. Direct to Consumer Pharmacy
9.4.2. Third Party Marketplace
9.5. Retail Pharmacy
9.5.1. Chain Pharmacy
9.5.2. Independent Pharmacy
10. Mumps Virus Vaccine Live Market, by Age Group
10.1. Introduction
10.2. Adolescent
10.3. Adult
10.4. Pediatric
11. Mumps Virus Vaccine Live Market, by Technology
11.1. Introduction
11.2. Dna Vaccine
11.3. Live Attenuated Vaccine
11.4. Recombinant Vaccine
12. Mumps Virus Vaccine Live Market, by Route of Administration
12.1. Introduction
12.2. Intramuscular
12.3. Subcutaneous
13. Mumps Virus Vaccine Live Market, by Dose Type
13.1. Introduction
13.2. Multi Dose
13.3. Single Dose
14. Mumps Virus Vaccine Live Market, by Formulation
14.1. Introduction
14.2. Liquid Solution
14.3. Lyophilized Powder
15. Americas Mumps Virus Vaccine Live Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Mumps Virus Vaccine Live Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Mumps Virus Vaccine Live Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Merck & Co., Inc.
18.3.2. GlaxoSmithKline plc
18.3.3. Serum Institute of India Pvt. Ltd.
18.3.4. China National Biotec Group Co., Ltd.
18.3.5. Walvax Biotechnology Co., Ltd.
18.3.6. Chengdu Institute of Biological Products Co., Ltd.
18.3.7. Beijing Institute of Biological Products Co., Ltd.
18.3.8. Shanghai Institute of Biological Products Co., Ltd.
18.3.9. PT Bio Farma (Persero)
18.3.10. Instituto Butantan
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. MUMPS VIRUS VACCINE LIVE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. MUMPS VIRUS VACCINE LIVE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. MUMPS VIRUS VACCINE LIVE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. MUMPS VIRUS VACCINE LIVE MARKET: RESEARCHAI
FIGURE 30. MUMPS VIRUS VACCINE LIVE MARKET: RESEARCHSTATISTICS
FIGURE 31. MUMPS VIRUS VACCINE LIVE MARKET: RESEARCHCONTACTS
FIGURE 32. MUMPS VIRUS VACCINE LIVE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MUMPS VIRUS VACCINE LIVE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MMR VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MMR VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MMRV VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MMRV VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SINGLE PATHOGEN VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SINGLE PATHOGEN VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMMUNITY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMMUNITY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DIRECT TO CONSUMER PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DIRECT TO CONSUMER PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ADOLESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DNA VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DNA VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 149. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2024 (USD MILLION)
TABLE 152. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2025-2030 (USD MILLION)
TABLE 153. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2018-2024 (USD MILLION)
TABLE 154. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2025-2030 (USD MILLION)
TABLE 155. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 158. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 159. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 162. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 163. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 174. CANADA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 184. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 185. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 192. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 193. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 200. MEXICO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 307. GERMANY MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 308. GERMANY MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 309. GERMANY MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2024 (USD MILLION)
TABLE 310. GERMANY MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2025-2030 (USD MILLION)
TABLE 311. GERMANY MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2018-2024 (USD MILLION)
TABLE 312. GERMANY MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, 2025-2030 (USD MILLION)
TABLE 313. GERMANY MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. GERMANY MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. GERMANY MUMPS VIRUS VACCINE LIVE MAR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Mumps Virus Vaccine Live market report include:
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Serum Institute of India Pvt. Ltd.
  • China National Biotec Group Co., Ltd.
  • Walvax Biotechnology Co., Ltd.
  • Chengdu Institute of Biological Products Co., Ltd.
  • Beijing Institute of Biological Products Co., Ltd.
  • Shanghai Institute of Biological Products Co., Ltd.
  • PT Bio Farma (Persero)
  • Instituto Butantan

Related Topics

Related Reports

Mumps Vaccine (MumpsVax) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Mumps Vaccine (MumpsVax) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Vaccine Market Report by Technology, Patient Type, Indication, Route of Administration, Product Type, Treatment Type, End User, Distribution Channel, and Region 2025-2033 - Product Image

Vaccine Market Report by Technology, Patient Type, Indication, Route of Administration, Product Type, Treatment Type, End User, Distribution Channel, and Region 2025-2033

  • Report
  • 144 Pages
  • Global
From
Respiratory Virus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Respiratory Virus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Pediatric Vaccines Market by Vaccine Type, by Technology, by Indication, by Distribution Channel, and by Region - Product Image

Pediatric Vaccines Market by Vaccine Type, by Technology, by Indication, by Distribution Channel, and by Region

  • Report
  • 200 Pages
  • Global
From
Chickenpox Vaccine Market Report 2025 - Product Image

Chickenpox Vaccine Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.